Imfinzi 120 MG/2.4 ML vial 2.4ML

Ended Awarded

Contract number
SPE2DR26F19FC
Awardee
Awarding agency
Obligated
$2,006

Award facts

Contract value 100% obligated
$2,005.92 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,005.92 by the Defense Logistics Agency on December 9, 2025, for the supply of IMFINZI 120 mg/2.4 mL vials. This firm fixed price delivery order, with a completion date of December 31, 2025, is performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The award was competitively procured with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This comprehensive prime vendor agreement enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally.

AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse medical supply requirements through open competition. The DLA's Pharmaceutical Prime Vendor Global Program Generation V initiative is planning multiple regional awards to support its medical supply chain operations, with AmerisourceBergen positioned to continue serving as a key provider of specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities.

Quick answers

Who was awarded contract SPE2DR26F19FC?

SPE2DR26F19FC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.

How much is contract SPE2DR26F19FC worth?

The government has obligated $2,006 on SPE2DR26F19FC.

Is contract SPE2DR26F19FC an order under another contract?

Yes. SPE2DR26F19FC is a delivery order under SPE2DR25D3301, an indefinite delivery contract.

Was contract SPE2DR26F19FC competed?

The extent of competition for SPE2DR26F19FC was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award